Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
93.28
-0.83 (-0.88%)
At close: Mar 9, 2026, 4:00 PM EDT
91.48
-1.80 (-1.93%)
After-hours: Mar 9, 2026, 7:19 PM EDT
Zimmer Biomet Holdings Revenue
In the year 2025, Zimmer Biomet Holdings had annual revenue of $8.23B with 7.20% growth. Zimmer Biomet Holdings had revenue of $2.24B in the quarter ending December 31, 2025, with 10.90% growth.
Revenue (ttm)
$8.23B
Revenue Growth
+7.20%
P/S Ratio
2.22
Revenue / Employee
$484,206
Employees
17,000
Market Cap
18.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.23B | 552.90M | 7.20% |
| Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
| Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
| Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
| Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.94B |
| GE HealthCare Technologies | 20.63B |
| Smith & Nephew | 6.16B |
| STERIS | 5.83B |
| DexCom | 4.66B |
| Globus Medical | 2.94B |
| Insulet | 2.71B |
| Bio-Rad Laboratories | 2.58B |
ZBH News
- 3 days ago - Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 12 days ago - Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting - PRNewsWire
- 14 days ago - Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 - PRNewsWire
- 18 days ago - Biggest S&P 500 Winners Last 5, 10, 20 Years - Seeking Alpha
- 27 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Zimmer Biomet beats quarterly estimates on strong hips, knees device demand - Reuters
- 27 days ago - Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 27 days ago - The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports - Seeking Alpha